Aldrich JV[Author] - Search Results

Year	Number of Results
1992	4
1993	3
1994	1
1995	1
1996	1
1997	3
1999	1
2000	4
2001	1
2002	2
2003	7
2004	2
2005	4
2007	1
2008	3
2009	10
2010	1
2011	5
2012	4
2013	4
2014	2
2015	1
2016	3
2017	3
2018	1
2020	4
2021	0

1

Phenylalanine Stereoisomers of CJ-15,208 and [d-Trp]CJ-15,208 Exhibit Distinctly Different Opioid Activity Profiles.

Brice-Tutt AC, Senadheera SN, Ganno ML, Eans SO, Khaliq T, Murray TF, McLaughlin JP, Aldrich JV. Brice-Tutt AC, et al. Among authors: aldrich jv. Molecules. 2020 Sep 2;25(17):3999. doi: 10.3390/molecules25173999. Molecules. 2020. PMID: 32887303 Free PMC article.

2

Design, Synthesis, and Characterization of the Macrocyclic Tetrapeptide cyclo[Pro-Sar-Phe-d-Phe]: A Mixed Opioid Receptor Agonist-Antagonist Following Oral Administration.

Ferracane MJ, Brice-Tutt AC, Coleman JS, Simpson GG, Wilson LL, Eans SO, Stacy HM, Murray TF, McLaughlin JP, Aldrich JV. Ferracane MJ, et al. Among authors: aldrich jv. ACS Chem Neurosci. 2020 May 6;11(9):1324-1336. doi: 10.1021/acschemneuro.0c00086. Epub 2020 Apr 21. ACS Chem Neurosci. 2020. PMID: 32251585

3

Multifunctional opioid receptor agonism and antagonism by a novel macrocyclic tetrapeptide prevents reinstatement of morphine-seeking behaviour.

Brice-Tutt AC, Wilson LL, Eans SO, Stacy HM, Simons CA, Simpson GG, Coleman JS, Ferracane MJ, Aldrich JV, McLaughlin JP. Brice-Tutt AC, et al. Among authors: aldrich jv. Br J Pharmacol. 2020 Sep;177(18):4209-4222. doi: 10.1111/bph.15165. Epub 2020 Jul 16. Br J Pharmacol. 2020. PMID: 32562259

4

Optimized Ring Closing Metathesis Reaction Conditions To Suppress Desallyl Side Products in the Solid-Phase Synthesis of Cyclic Peptides Involving Tyrosine(O-allyl).

Gisemba SA, Aldrich JV. Gisemba SA, et al. Among authors: aldrich jv. J Org Chem. 2020 Feb 7;85(3):1407-1415. doi: 10.1021/acs.joc.9b02345. Epub 2020 Jan 13. J Org Chem. 2020. PMID: 31880448

5

Analytical and biological methods for probing the blood-brain barrier.

Kuhnline Sloan CD, Nandi P, Linz TH, Aldrich JV, Audus KL, Lunte SM. Kuhnline Sloan CD, et al. Among authors: aldrich jv. Annu Rev Anal Chem (Palo Alto Calif). 2012;5:505-31. doi: 10.1146/annurev-anchem-062011-143002. Annu Rev Anal Chem (Palo Alto Calif). 2012. PMID: 22708905 Free PMC article. Review.

6

Alanine scan of the opioid peptide dynorphin B amide.

Joshi AA, Murray TF, Aldrich JV. Joshi AA, et al. Among authors: aldrich jv. Biopolymers. 2017 Sep;108(5):10.1002/bip.23026. doi: 10.1002/bip.23026. Biopolymers. 2017. PMID: 28464209 Free PMC article.

7

Pathobiology of dynorphins in trauma and disease.

Hauser KF, Aldrich JV, Anderson KJ, Bakalkin G, Christie MJ, Hall ED, Knapp PE, Scheff SW, Singh IN, Vissel B, Woods AS, Yakovleva T, Shippenberg TS. Hauser KF, et al. Among authors: aldrich jv. Front Biosci. 2005 Jan 1;10:216-35. doi: 10.2741/1522. Print 2005 Jan 1. Front Biosci. 2005. PMID: 15574363 Free PMC article. Review.

8

Peptide kappa opioid receptor ligands: potential for drug development.

Aldrich JV, McLaughlin JP. Aldrich JV, et al. AAPS J. 2009 Jun;11(2):312-22. doi: 10.1208/s12248-009-9105-4. Epub 2009 May 9. AAPS J. 2009. PMID: 19430912 Free PMC article. Review.

9

Opioid Peptides: Potential for Drug Development.

Aldrich JV, McLaughlin JP. Aldrich JV, et al. Drug Discov Today Technol. 2012;9(1):e23-e31. doi: 10.1016/j.ddtec.2011.07.007. Drug Discov Today Technol. 2012. PMID: 23316256 Free PMC article.

10

Structure-Activity Relationships of the Peptide Kappa Opioid Receptor Antagonist Zyklophin.

Joshi AA, Murray TF, Aldrich JV. Joshi AA, et al. Among authors: aldrich jv. J Med Chem. 2015 Nov 25;58(22):8783-95. doi: 10.1021/jm501827k. Epub 2015 Nov 16. J Med Chem. 2015. PMID: 26491810 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results